Cardiovascular Systems Director John Friedman Unloads 48,273 Shares (CSII)
Cardiovascular Systems (NASDAQ:CSII) Director John Friedman sold 48,273 shares of the stock in a transaction dated Tuesday, September 10th. The shares were sold at an average price of $20.73, for a total value of $1,000,699.29. Following the transaction, the director now directly owns 8,000 shares of the company’s stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link.
Several analysts have recently commented on the stock. Analysts at Benchmark Co. initiated coverage on shares of Cardiovascular Systems (NASDAQ:CSII) in a research note to investors on Tuesday. They set a “speculative buy” rating and a $26.00 price target on the stock. Separately, analysts at Feltl & Co. upgraded shares of Cardiovascular Systems (NASDAQ:CSII) from a “buy” rating to a “strong-buy” rating in a research note to investors on Thursday, August 8th. They now have a $27.50 price target on the stock, up previously from $19.50. Finally, analysts at Wunderlich initiated coverage on shares of Cardiovascular Systems (NASDAQ:CSII) in a research note to investors on Friday, July 26th. They set a “buy” rating and a $24.00 price target on the stock.
Four research analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. The company has a consensus rating of “Buy” and an average price target of $26.30.
Cardiovascular Systems (NASDAQ:CSII) traded down 0.05% on Friday, hitting $21.00. The stock had a trading volume of 50,328 shares. Cardiovascular Systems has a 1-year low of $10.00 and a 1-year high of $22.84. The stock has a 50-day moving average of $20.70 and a 200-day moving average of $19.74. The company’s market cap is $507.8 million.
Cardiovascular Systems (NASDAQ:CSII) last released its earnings data on Wednesday, August 7th. The company reported ($0.28) EPS for the quarter, beating the Thomson Reuters consensus estimate of ($0.30) by $0.02. The company had revenue of $28.80 million for the quarter, compared to the consensus estimate of $27.18 million. On average, analysts predict that Cardiovascular Systems will post $-1.15 earnings per share for the current fiscal year.
Cardiovascular Systems, Inc (NASDAQ:CSII) is a medical device company.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.